Equities are a key component of every investor’s portfolio, making it important to learn the fundamentals and technicals required to invest successfully and with confidence. Discover how top professional investors separate fact from fiction to maximize their profit opportunities. From explosive IPOs to solid value plays, our experts can help you formulate the right action plan for your portfolio no matter where the markets are headed.

Articles on Stocks

When the market was bottoming on October 13 of 2022 at 3500SPX, the members of ElliottWaveTrader knew to begin looking up to the 4100SPX region for an initial rally off those lows, explains Avi Gilburt of
Good morning! This is Mike Larson, your Editor-in-Chief at MoneyShow. Today, we’re rolling out a new feature for your Top Pros Top Picks newsletter...The MoneyShow Market Minute.
The year 2022 is in the rear-view mirror, and most investors are glad to see it go. While my subscribers did better than most investors, we could not aggressively get money to work and only have a handful of positions so far. I expect that to change rapidly in 2023, says Tim Melvin, editor of The 20% Letter.
Investors hate uncertainty. So, it’s understandable that Dominion Energy (D) shares sold off in early November when the company replaced its CFO and announced a “top to bottom” strategic review. But after a rough 2022, Dominion shares are priced for low expectations with multiple upside drivers, remarks Roger Conrad, editor of Conrad’s Utility Investor.
The stock market loved “Happy Jay Powell” yesterday, with equities rallying strongly off their pre-Federal Open Market Committee lows. The Nasdaq was the big winner, gaining XX%, and tech names are looking strong again this morning.
When one of the biggest and most important companies ever announces a fiscal push toward the use of artificial intelligence (AI), you know things are starting to get serious, suggests Jim Woods, editor of The Deep Woods.
Stock market bulls have been rewarded over the past three months. Remember, historically these are the best three months of the year—November through January. And then comes the hangover, states JC Parets of
Short-term bear trade signals appear on swing-trading charts and time frames, writes Trevor Smith of Trevor's Trading.
Johnson & Johnson (JNJ) is an American healthcare conglomerate involved in the production and distribution of pharmaceuticals, consumer package goods and medical devices, and the stock should continue outperforming, says Sean Brodrick, editor of Wealth Megatrends.
We see Tesla (TSLA) as the undisputed leader in the electric vehicle (EV) industry despite growing competition. We view the selloff in TSLA shares as overdone and believe that it offers investors a favorable buying opportunity, underscores Bill Selesky, an analyst at Argus Research.

Experts on Stocks

Virtual Expos

Virtual Learning

Join us for a short briefing and booth tour of Hornet, Noyack Capital, Akru, and The GSH Group.

John McCamant has spent 35 years on the front lines of biotech investing as an equities analyst and in venture capital. He has also edited the Medical Technology Stock Letter since the year 2000. In this session, he'll tell you about the methodology he uses to sift through hundreds of biotech companies to find the best in class drugs like MDGL for long-term growth. Plus, John will highlight the most attractive biotech opportunities in this premier growth sector for the rest of 2023 and beyond.

IBD's MarketDiem newsletter gives you hand-picked trade ideas for stocks and options right in your inbox every weekday during market hours. Their team does the research, so you get smarter trading insights, timely market analysis and even bite-size investing lessons--all in a quick 5-minute read. Subscribe today for $4.99 per month or just $20 for the entire year.
Join us for a short briefing and booth tour of Percent, Rise48 Equity, Ignite Funding, Axiom Capital, and GroCapitus

Neurostreet will be presenting a unique and unprecedented fin-tech acquisition for market-disrupting trading tech. Imagine a trading platform built for both quants/institutions & retail traders, with a robust feature set across all asset classes (ie. futures, forex, equities, and crypto) - from custom indicators & algos for discretionary traders, to backtesting and optimization for quants, this technology is about to make noise the trading space didn't see coming! Servicing both retail traders and institutional firms simultaneously, NeuroStreet will soon be the world's most advanced "hybrid" trading platform. Please join us for this jam-packed presentation as NeuroStreet presents its Series A Fundraising and positions investors for the next trading fin-tech unicorn!

It took 16 years for the NASDAQ to recover from its 80% "dot com" meltdown and 6 years for the S&P 500 after its 56% correction during the Great Recession. If this bear market follows suit, there's more selling to come in 2023. So, why not diversify with a portfolio solution that is a proven hedge (double-digit returns in 2022) for stock market exposure?

Unlike most alternatives, InvestiQuant's sophisticated, fully automated solutions trade your account for you--along with our founders' accounts and hundreds of other investors--providing you with 100% visibility, access, and control. Join former public tech company CEO, Scott Andrews, and see if an institutional quality auto-trading program might be just what your portfolio is missing.

During times of economic uncertainty, investors often look for lower-risk investments that continue to generate strong, consistent returns. In this presentation, investor, fund manager, advisor, and author J Scott will discuss preferred equity, an investment vehicle that appeals to many seasoned investors during times of economic turmoil. Find out how preferred equity investments work and how they can significantly reduce the risk of investment loss while providing strong, consistent returns, along with potential tax benefits and diversification.

Join us as we review last year's performance from the simple trend following benchmark published every minute of every trading day since 2014. After a disastrous year in the 60/40 stock bond portfolio, couldn't your portfolio use some diversification? Not everyone had a bad 2022will also provide examples of applying this model to equities and cryptos.

This is a follow-up to the best ideas for 2022, Renren (RENN), which more than doubled. It's safe, lucrative, and uncorrelated with the broader equity market. This is one of my hedge fund's top positions and top ideas on Sifting the World.

A preview of select companies during this event.



While the mechanisms and machinations of the markets have changed a lot since Benjamin Graham first devised a practical method for analyzing stocks, or even since Peter Lynch racked up big wins picking equities for Fidelity's Magellan Fund, one thing remains true: companies that deliver constant profits for shareholders will see their share prices increase.

Lofty current valuations show that the easy money has already been made, and those looking to profit should be more selective going forward. So which sectors will lead the market over the months ahead? What’s the best way to limit risk in the current environment? You will find the answers to these questions and more from the top industry professionals on these pages, unlike watching the stock market news on TV. Going beyond the stock market news today, many investors are searching for investments that they can depend on. Of course, there's no such thing as a sure bet, but the top experts featured here will share the picks they think are the next best things and the sectors that are bound to thrive in the days and months ahead.

The current market environment is particularly well-suited for stock pickers and stock-trading experts—especially the experts featured here whose careers are devoted to uncovering the best opportunities available in even the most rapidly changing environment. Get easy access to the nation’s leading stock experts who regularly share their takes on where market trends are headed, where to find bargains, and how to stay ahead of the curve.

Watch videos and read articles by these experts and discover their outlooks on what’s ahead for stocks, but more importantly, identify the most compelling sectors and industry groups, as well as the specific buying opportunities for optimal growth or income. These pages are chock-full of valuable insights from our experts' varying perspectives and expertise.